Veterinary Medicines

Domosedan 10 mg/ml suspension injectable

Authorised
  • Detomidine
Download as PDF

Product identification

Medicine name:
Domosedan 10 mg/ml suspension injectable
Domosedan 10 mg/ml Injektionslösung
Active substance:
  • Detomidine
Target species:
  • Horse
  • Cattle
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Detomidine
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Milk
        no withdrawal period
      • Meat and offal
        24
        hour
    • Cattle
      • Milk
        no withdrawal period
      • Meat and offal
        24
        hour
  • Intravenous use
    • Horse
      • Milk
        no withdrawal period
      • Meat and offal
        24
        hour
    • Cattle
      • Milk
        no withdrawal period
      • Meat and offal
        24
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • Domosedan 5 ml Vial Suspension for injection
  • Domosedan 20 ml Vial Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Orion Corporation
Marketing authorisation date:
Manufacturing sites for batch release:
  • Orion Corporation
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 087/92/02/0237
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 23/01/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."